(EDEN) Edenred - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0010908533
Stock: Employee Benefits, Mobility, Payments
Total Rating 36
Risk 62
Buy Signal -0.21
| Risk 5d forecast | |
|---|---|
| Volatility | 36.9% |
| Relative Tail Risk | -10.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.04 |
| Alpha | -47.38 |
| Character TTM | |
|---|---|
| Beta | 0.282 |
| Beta Downside | 0.789 |
| Drawdowns 3y | |
|---|---|
| Max DD | 70.42% |
| CAGR/Max DD | -0.40 |
Description: EDEN Edenred March 01, 2026
Edenred SE (ticker EDEN) is a French-based digital platform that delivers employee benefit, mobility, and complementary payment solutions to corporations, workers, and merchants worldwide. Its portfolio spans meal-voucher programs such as Ticket Restaurant and Ticket Alimentación, gift-voucher and cultural-goods offerings, as well as fuel-card, fleet-management, and electric-vehicle-charging services like Spirii.
In FY 2023 Edenred generated €6.0 billion in revenue, up 4.2 % YoY, with an EBITDA margin of roughly 15 % and net profit margin of 5.5 %. The Q1 2024 results showed a further 5 % revenue increase, driven by strong adoption of its digital ticketing solutions and expanding demand for sustainable-focused products such as EcoCheque, which benefits from EU green-spending incentives. The company’s growth is also supported by macro-trends like rising corporate spending on employee well-being and the broader shift toward cash-less, cloud-based payment platforms in the diversified support services sector.
For a deeper dive, see the ValueRay analysis of EDEN.
Headlines to watch out for
- Employee benefit solution adoption drives recurring revenue growth
- Mobility solution expansion increases market share
- Regulatory changes impact digital payment platform profitability
- Economic downturns reduce corporate spending on employee benefits
- Competition from fintech platforms pressures pricing and margins
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 1.03b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 4.28 > 1.0 |
| NWC/Revenue: -7.38% < 20% (prev -21.77%; Δ 14.40% < -1%) |
| CFO/TA 0.14 > 3% & CFO 1.96b > Net Income 1.03b |
| Net Debt (-420.0m) to EBITDA (2.34b): -0.18 < 3 |
| Current Ratio: 0.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (221.4m) vs 12m ago -16.40% < -2% |
| Gross Margin: 49.32% > 18% (prev 0.54%; Δ 4877 % > 0.5%) |
| Asset Turnover: 39.76% > 50% (prev 28.36%; Δ 11.40% > 0%) |
| Interest Coverage Ratio: 5.85 > 6 (EBITDA TTM 2.34b / Interest Expense TTM 316.0m) |
Altman Z'' 0.23
| A: -0.03 (Total Current Assets 8.86b - Total Current Liabilities 9.25b) / Total Assets 13.57b |
| B: -0.14 (Retained Earnings -1.86b / Total Assets 13.57b) |
| C: 0.14 (EBIT TTM 1.85b / Avg Total Assets 13.43b) |
| D: -0.06 (Book Value of Equity -818.0m / Total Liabilities 14.39b) |
| Altman-Z'' Score: 0.23 = B |
Beneish M -3.24
| DSRI: 0.31 (Receivables 1.46b/3.36b, Revenue 5.34b/3.77b) |
| GMI: 1.10 (GM 49.32% / 54.43%) |
| AQI: 1.05 (AQ_t 0.34 / AQ_t-1 0.32) |
| SGI: 1.42 (Revenue 5.34b / 3.77b) |
| TATA: -0.07 (NI 1.03b - CFO 1.96b) / TA 13.57b) |
| Beneish M-Score: -3.24 (Cap -4..+1) = AA |
What is the price of EDEN shares?
As of March 11, 2026, the stock is trading at EUR 18.86 with a total of 708,965 shares traded.
Over the past week, the price has changed by -2.36%, over one month by +4.78%, over three months by +4.14% and over the past year by -42.56%.
Over the past week, the price has changed by -2.36%, over one month by +4.78%, over three months by +4.14% and over the past year by -42.56%.
Is EDEN a buy, sell or hold?
Edenred has no consensus analysts rating.
What are the forecasts/targets for the EDEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.9 | 42.4% |
| Analysts Target Price | - | - |
EDEN Fundamental Data Overview March 09, 2026
Market Cap USD = 5.07b (4.41b EUR * 1.1513 EUR.USD)
P/E Trailing = 8.5023
P/E Forward = 8.15
P/S = 1.6124
P/EG = 0.937
Revenue TTM = 5.34b EUR
EBIT TTM = 1.85b EUR
EBITDA TTM = 2.34b EUR
Long Term Debt = 3.88b EUR (from longTermDebt, two quarters ago)
Short Term Debt = 1.27b EUR (from shortTermDebt, two quarters ago)
Debt = 4.83b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -420.0m EUR (from netDebt column, last quarter)
Enterprise Value = 3.99b EUR (4.41b + Debt 4.83b - CCE 5.25b)
Interest Coverage Ratio = 5.85 (Ebit TTM 1.85b / Interest Expense TTM 316.0m)
EV/FCF = 2.43x (Enterprise Value 3.99b / FCF TTM 1.64b)
FCF Yield = 41.23% (FCF TTM 1.64b / Enterprise Value 3.99b)
FCF Margin = 30.76% (FCF TTM 1.64b / Revenue TTM 5.34b)
Net Margin = 19.25% (Net Income TTM 1.03b / Revenue TTM 5.34b)
Gross Margin = 49.32% ((Revenue TTM 5.34b - Cost of Revenue TTM 2.71b) / Revenue TTM)
Gross Margin QoQ = 61.59% (prev 42.87%)
Tobins Q-Ratio = 0.29 (Enterprise Value 3.99b / Total Assets 13.57b)
Interest Expense / Debt = 2.36% (Interest Expense 114.0m / Debt 4.83b)
Taxrate = 30.18% (134.0m / 444.0m)
NOPAT = 1.29b (EBIT 1.85b * (1 - 30.18%))
Current Ratio = 0.96 (Total Current Assets 8.86b / Total Current Liabilities 9.25b)
Debt / Equity = -5.90 (negative equity) (Debt 4.83b / totalStockholderEquity, last quarter -818.0m)
Debt / EBITDA = -0.18 (Net Debt -420.0m / EBITDA 2.34b)
Debt / FCF = -0.26 (Net Debt -420.0m / FCF TTM 1.64b)
Total Stockholder Equity = -956.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.65% (Net Income 1.03b / Total Assets 13.57b)
RoE = -107.5% (negative equity) (Net Income TTM 1.03b / Total Stockholder Equity -956.5m)
RoCE = 63.17% (EBIT 1.85b / Capital Employed (Equity -956.5m + L.T.Debt 3.88b))
RoIC = 35.10% (NOPAT 1.29b / Invested Capital 3.68b)
WACC = 4.18% (E(4.41b)/V(9.23b) * Re(6.96%) + D(4.83b)/V(9.23b) * Rd(2.36%) * (1-Tc(0.30)))
Discount Rate = 6.96% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -8.56%
[DCF] Terminal Value 88.43% ; FCFF base≈1.40b ; Y1≈1.73b ; Y5≈2.95b
[DCF] Fair Price = 367.7 (EV 85.79b - Net Debt -420.0m = Equity 86.21b / Shares 234.4m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 30.31 | EPS CAGR: 141.8% | SUE: -0.37 | # QB: 0
Revenue Correlation: 74.72 | Revenue CAGR: 50.73% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=2.14 | Chg7d=-0.040 | Chg30d=-0.018 | Revisions Net=+2 | Growth EPS=-17.3% | Growth Revenue=-1.5%
EPS next Year (2027-12-31): EPS=2.40 | Chg7d=-0.005 | Chg30d=-0.039 | Revisions Net=-2 | Growth EPS=+12.2% | Growth Revenue=+6.5%
[Analyst] Revisions Ratio: +0.20 (6 Up / 4 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -3.8% (Discount Rate 7.9% - Earnings Yield 11.8%)
[Growth] Growth Spread = +10.3% (Analyst 6.5% - Implied -3.8%)
P/E Trailing = 8.5023
P/E Forward = 8.15
P/S = 1.6124
P/EG = 0.937
Revenue TTM = 5.34b EUR
EBIT TTM = 1.85b EUR
EBITDA TTM = 2.34b EUR
Long Term Debt = 3.88b EUR (from longTermDebt, two quarters ago)
Short Term Debt = 1.27b EUR (from shortTermDebt, two quarters ago)
Debt = 4.83b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -420.0m EUR (from netDebt column, last quarter)
Enterprise Value = 3.99b EUR (4.41b + Debt 4.83b - CCE 5.25b)
Interest Coverage Ratio = 5.85 (Ebit TTM 1.85b / Interest Expense TTM 316.0m)
EV/FCF = 2.43x (Enterprise Value 3.99b / FCF TTM 1.64b)
FCF Yield = 41.23% (FCF TTM 1.64b / Enterprise Value 3.99b)
FCF Margin = 30.76% (FCF TTM 1.64b / Revenue TTM 5.34b)
Net Margin = 19.25% (Net Income TTM 1.03b / Revenue TTM 5.34b)
Gross Margin = 49.32% ((Revenue TTM 5.34b - Cost of Revenue TTM 2.71b) / Revenue TTM)
Gross Margin QoQ = 61.59% (prev 42.87%)
Tobins Q-Ratio = 0.29 (Enterprise Value 3.99b / Total Assets 13.57b)
Interest Expense / Debt = 2.36% (Interest Expense 114.0m / Debt 4.83b)
Taxrate = 30.18% (134.0m / 444.0m)
NOPAT = 1.29b (EBIT 1.85b * (1 - 30.18%))
Current Ratio = 0.96 (Total Current Assets 8.86b / Total Current Liabilities 9.25b)
Debt / Equity = -5.90 (negative equity) (Debt 4.83b / totalStockholderEquity, last quarter -818.0m)
Debt / EBITDA = -0.18 (Net Debt -420.0m / EBITDA 2.34b)
Debt / FCF = -0.26 (Net Debt -420.0m / FCF TTM 1.64b)
Total Stockholder Equity = -956.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.65% (Net Income 1.03b / Total Assets 13.57b)
RoE = -107.5% (negative equity) (Net Income TTM 1.03b / Total Stockholder Equity -956.5m)
RoCE = 63.17% (EBIT 1.85b / Capital Employed (Equity -956.5m + L.T.Debt 3.88b))
RoIC = 35.10% (NOPAT 1.29b / Invested Capital 3.68b)
WACC = 4.18% (E(4.41b)/V(9.23b) * Re(6.96%) + D(4.83b)/V(9.23b) * Rd(2.36%) * (1-Tc(0.30)))
Discount Rate = 6.96% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -8.56%
[DCF] Terminal Value 88.43% ; FCFF base≈1.40b ; Y1≈1.73b ; Y5≈2.95b
[DCF] Fair Price = 367.7 (EV 85.79b - Net Debt -420.0m = Equity 86.21b / Shares 234.4m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 30.31 | EPS CAGR: 141.8% | SUE: -0.37 | # QB: 0
Revenue Correlation: 74.72 | Revenue CAGR: 50.73% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=2.14 | Chg7d=-0.040 | Chg30d=-0.018 | Revisions Net=+2 | Growth EPS=-17.3% | Growth Revenue=-1.5%
EPS next Year (2027-12-31): EPS=2.40 | Chg7d=-0.005 | Chg30d=-0.039 | Revisions Net=-2 | Growth EPS=+12.2% | Growth Revenue=+6.5%
[Analyst] Revisions Ratio: +0.20 (6 Up / 4 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -3.8% (Discount Rate 7.9% - Earnings Yield 11.8%)
[Growth] Growth Spread = +10.3% (Analyst 6.5% - Implied -3.8%)